Collaboration is key: solar and wind energy sufficient for industrialized energy demands
BioTechniques News Tristan Free Researchers find that a combination of solar and wind power could supply 85% of US energy, which would […]
Category: News
Got wellies? Sea levels rise as a result of accelerated Greenland ice sheet melting
BioTechniques News Aisha Al-Janabi When was the last time you jumped in a puddle? Satellite data-informed research suggests that global warming caused ice […]
CMS’s Own Data Do NOT Support Claims on Part B Drug Spending
BIOtech Now Dan Durham In a story entitled, “CMS Blames Medicare Part B Hikes on Drug Costs,” writers for Politico Pulse note: […]
In Speaker Pelosi’s Extreme Drug Pricing Bill, Funding for NIH is MIA
BIOtech Now Brian Newell Supporters of Speaker Pelosi’s extreme drug pricing bill (H.R. 3) want us to believe that they can destroy […]
#BIOSummit19 Concludes with Message of Hope Offered by Innovation
BIOtech Now Theresa Brady Representing all facets of the patient stakeholder community, participants in BIO’s eighth Patient and Health Advocacy Summit (#BIOSummit19) […]
#BIOSummit19: Education and Partnerships Raise Awareness
BIOtech Now Theresa Brady When Mark Dant’s son Ryan was first diagnosed with MPS-I, a rare genetic disorder that leads to organ […]
Greenwood: Solving the Looming Superbug Crisis Will Require Bold Action From Congress
BIOtech Now Andrew Segerman Writing for Morning Consult, BIO’s Jim Greenwood discusses the challenges of developing novel antibiotics and highlights the urgent […]
Fundraising Companies Find Strategic Partners that Best Fit Their Stage of Development at BIO Investor Forum
BIOtech Now Rufael Seyum Since its inception 17 years ago, the BIO Investor Forum has become the premier event where biotech innovators […]
Investment Crackdown Prompts Chinese Investors to Leave U.S. Biotech Market and Focus on Europe
BIOtech Now Rufael Seyum Confusion among Chinese investors about shifting U.S. regulatory policy is draining billions of dollars from the American biotechnology […]
BIO Mourns Passing of Dr. John Holaday
BIOtech Now Jim Greenwood On behalf of the team at BIO, we send our deepest condolences to the family of Dr. John […]
#TBT: Debunking Some Common Myths on Patent Protections
BIOtech Now Andrew Segerman The Subcommittee on Consumer Protection and Commerce of the Committee on Energy and Commerce is set to examine […]
The Challenges and Risks of Adopting Foreign Price Controls
BIOtech Now Andrew Segerman The Trump Administration is moving forward with a plan to import foreign price controls into Medicare. Under the […]
As Mosquito Fears Rise, EPA Considers Oxitec 2nd Generation Trial
BIOtech Now Karen Batra Most people consider mosquitoes to be a summertime pest – the unwelcome guest at the backyard barbecue. More […]
ICYMI: Biopharmaceutical Companies Aren’t Free-Riding on Government Research
BIOtech Now Andrew Segerman Writing for the Boston Globe, Dr. Michael Rosenblatt, chief medical officer of the venture firm Flagship Pioneering, debunks […]
Discrimination Against Vulnerable Patients Is Nothing New
BIOtech Now Andrew Segerman Transformative therapies are advancing like never before, and a new class of medicines are changing the way we […]
National Immunization Awareness Month Is a Reminder About the Value of Vaccines
BIOtech Now Andrew Segerman Writing for Morning Consult, Dr. Judy Monroe, president and CEO of the CDC Foundation, highlights the importance of […]
The BIO Investor Forum Links Promising Early-Stage Technologies with an Active Investor Network
BIOtech Now Nareg Sagherian As the biopharma industry has gained traction on new drug approvals throughout 2019, the financial dollars have followed […]
New Coalition to Raise Awareness of Antimicrobial Resistance Threat, Call for Urgent Solutions
BIOtech Now Andrew Segerman The Biotechnology Innovation Organization (BIO), leading scientists, public policy experts, and industry leaders today announced the launch of […]
BIO’s Jim Greenwood Talks Pricing, Policy and Science on CSPAN
BIOtech Now Andrew Segerman BIO’s Jim Greenwood joined CSPAN’s Washington Journal for a conversation about drug pricing, the latest proposals being considered […]
Biotech Leaders Warn: Shortsighted Policies Threaten Miracle Breakthroughs
BIOtech Now Andrew Segerman Writing for STAT News, Paul Hastings – CEO of Nkarta Therapeutics and Vice Chair of BIO’s Board – […]